A practical reference on lyophilized powder: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-06-14. Anything still debated is marked as such rather than presented as settled.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 4963 Da for full-length thymosin beta-4 | Value applies to the parent protein; fragment products may differ |
| Appearance | White to off-white lyophilized powder | Typical form of supplied synthetic peptide |
| Solubility | Freely soluble in water | Polar peptide; dissolves readily in aqueous buffer |
| Storage of dry powder | −20 °C, desiccated, protected from light | Standard laboratory practice for peptides |
| Typical detection method | Liquid chromatography–tandem mass spectrometry | Used in purity testing and anti-doping analysis |
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
Identity and purity are assessed with a small set of standard techniques. Reverse-phase high-performance liquid chromatography gives a purity estimate from peak area, usually recorded at 214 or 220 nanometers, where the peptide bond absorbs. Mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidized species. Amino acid analysis or tandem mass spectrometry sequencing can verify the sequence itself. Additional quality attributes include water content, residual trifluoroacetic acid carried over from purification, and endotoxin where the material is intended for biological work.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
In 2019, shortly after Buc-ee's opened their first store in Alabama, the company was sued for "setting unfair pump prices", because they were selling gasoline to the customers for less money than it costs to buy and transport it to a retail outlet. While it is common within the United States for larger gas station chains to use a pricing strategy where gas is used as a loss leader to draw customers and encourage the sale of other goods, the practice is banned under Alabama state law. Buc-ee's also lost a Texas Employee Retention Agreement case on appeal in 2017. A year after a trial court ordered a former employee to pay Buc-ee's close to $100,000 in damages and attorney's fees for breaching a "retention agreement," a Texas court of appeals reversed the decision and ordered that Buc-ee's receive nothing for its claims against the former employee. The court reasoned that the contract violated Texas's employment-at-will doctrine and did not meet the Texas non-compete agreement requirements, so it was not enforceable. In 2023, crossover artwork of the Buc-ee's beaver and Hatsune Miku was trending on Twitter. An Austin-based artist claimed responsibility for creating "Bucsune Miku". In response, Buc-ee's sent the artist a cease and desist letter regarding the stickers and the use of the beaver logo. The artist withdrew the stickers.
(p) .signature (UNIX shell/Internet standard file name) (a/i) Special Interest Group (a/i) Strasbourg Illkirch-Graffenstaden Basket (French basketball club) SIGCAT – (a) Special Interest Group for CD-ROM Applications and Technology SIGINT – (p) Signals Intelligence SIGMET – (p) Significant Meteorological Information SIIT (i) Saskatchewan Indian Institute of Technologies (Canadian university) Sirindhorn International Institute of Technology (Thai university) Stateless IP/ICMP Translation algorithm SIMAC – (a) Semantic Interaction with Music Audio Contents SIMLAS – (p) Soldier Integrated Multipurpose Laser System SIMM – (a) Single In-line Memory Module SIMNET – (p) SIMulator NETwork, later SIMulation NETwork SIMNET-D - (p) SIMNET-Developmental SIMP – (a) Strongly Interacting Massive Particle SIMPLE (a) Satellite Interactive Multimedia Platform for Low-cost Earth stations (p) Savings Incentive Match Plan for Employees (as used in SIMPLE IRA) (a) Standard Interface for Multiple Platform Link Evaluation (NATO STANAG 5602) sin – (s) Sinhala language (ISO 639-2 code) SIN – (a) Social insurance number (Canada) SINCGARS – (p) SINgle Channel Ground and Airborne Radio System SIP (i) Session Initiation Protocol State Implementation Plan System Improvement Program Systematic investment plan SIPP – (a) Self-Invested Personal Pension Siri – (a) Speech Interpretation and Recognition Interface (Apple iOS software) SIRI – (a) Service Interface for Real Time Information SIRS — (a) Systemic inflammatory response syndrome SiS – (i) Silicon Integrated Systems SIS – (i) UK Secret Intelligence Service (also known as MI6) SISO (a) Simulation Interoperability Standards Organization Society of Independent Show Organizers SIW – (i) Simulation Interoperability Workshop SIYSS – (i) Stockholm International Youth Science Seminar
Before a recipient receives a transfusion, compatibility testing between donor and recipient blood must be done. The first step before a transfusion is given is to type and screen the recipient's blood. Typing of recipient's blood determines the ABO and Rh status. The sample is then screened for any alloantibodies that may react with donor blood. It takes about 45 minutes to complete (depending on the method used). The blood bank scientist also checks for special requirements of the patient (e.g. need for washed, irradiated or CMV negative blood) and the history of the patient to see if they have previously identified antibodies and any other serological anomalies.
carrier protein 1. A membrane protein that functions as a transporter, binding to a solute and facilitating its movement across the membrane by undergoing a series of conformational changes. 2. A protein to which a specific ligand or hapten has been conjugated and which thereby carries an antigen capable of eliciting an antibody response. 3. A protein which is included in an assay at high concentrations in order to prevent non-specific interactions of the assay's reagents with vessel surfaces, sample components, or other reagents. For example, in many blotting techniques, albumin is intentionally allowed to bind non-specifically to the blotted membrane prior to fluorescent labelling, so as to "block" potential off-target binding of the fluorophore to the membrane, which might otherwise cause background fluorescence that obscures genuine signal from the target.
Sources: en.wikipedia.org
From then on, Suhner ran the business by himself. Studer, on the other hand, went on to found his own company "Willi Studer", known as Studer today and famous for its audio equipment. In 1968, Bertold Suhner resigned from his post in the operational management of Metrohm and became strongly committed to the environment. He even fought for causes that could harm his own company, making it a difficult time for the new managing directors Lorenz Kuhn and Hans Winzeler. As a result of his intransigence in environmental matters, he also alienated friends, leaving him socially isolated towards the end of his life. Since 1982, Metrohm AG has been a full subsidiary of the Metrohm Foundation, which is the only shareholder of Metrohm AG. Metrohm co-founder Bertold Suhner put the foundation in place to ensure independence and thereby maintain the ability to make unswayed decisions. The foundation is not only dedicated to the operation of Metrohm AG, but also to charitable and cultural purposes. For example, in 1999, the Metrohm Foundation equipped the public gymnasium Kantonsschule Trogen in the Swiss town of Trogen with internet access and more than 100 computer workstations to ensure that the public school can keep up with international standards. It has also endowed a professorship for the research on new materials at the Zurich University of Applied Sciences since 2014. Until 2006, 36 subsidiaries had been founded. For the most part, these are situated abroad and form a worldwide support and sales network.
Boomf raised $1m of funding in 2021, but by December 2021 the company had fallen into administration owing £800,000 to creditors, including £146,306 to HM Revenue and Customs. Creditors voluntary liquidation commenced on 4 November 2022.
=== Pharmacokinetics === Drostanolone propionate is not active via the oral route and must be administered via intramuscular injection. The elimination half-life of the drug via this route is approximately 2 days. It has a much longer elimination half-life via intramuscular injection than drostanolone. Drostanolone propionate is metabolized into drostanolone, which is the active form.
Sources: en.wikipedia.org
assimilatory process Any process by which chemical compounds containing biologically relevant elements (e.g. carbon, hydrogen, oxygen, nitrogen, phosphorus, sulfur, selenium, iron, cobalt, nickel, copper, zinc, molybdenum, etc.) are uptaken by microorganisms and incorporated into complex biomolecules in order to synthesize various cellular components. In contrast, a dissimilatory process uses the energy released by decomposing exogenous molecules to power the cell's metabolism and excretes residual or toxic compounds out of the cell, instead of reusing them to build new molecules.
== Functions == LCRs were originally thought as 'junk' regions or as neutral linkers between domains; however, experimental and computational evidence increasingly indicates that they may play important adaptive and conserved roles, relevant to biotechnology, heterologous protein expression, medicine, as well as to our understanding of protein evolution. LCRs of eukaryotic proteins have been involved in human diseases, especially neurodegenerative ones, where they tend to form amyloids in humans and other eukaryotes. They have been reported to have adhesive roles, function in excreted sticky proteins used for prey capture, or have roles as transducers of molecular movement, e.g. in the prokaryotic TonB/TolA systems. LCRs may form surfaces for interaction with phospholipid bilayers, or as positive charge clusters for DNA binding, or as negative or even histidine-acidic charge clusters for coordinating calcium, magnesium or zinc ions. They may also play important roles in protein translation, as tRNA 'sponges', slowing down translation in order to allow time for the correct folding of the nascent polypeptide chain. They may even function as frame-shift checkpoints, by shifting to an unusual amino acid content that makes the protein highly unstable or insoluble, which in turn triggers fast recycling, before any further cellular damage.
Δp is the pressure difference between the two ends, L is the length of pipe, μ is the dynamic viscosity, Q is the volumetric flow rate, R is the pipe radius, A is the cross-sectional area of pipe. The equation does not hold close to the pipe entrance. The equation fails in the limit of low viscosity, wide and/or short pipe. Low viscosity or a wide pipe may result in turbulent flow, making it necessary to use more complex models, such as the Darcy–Weisbach equation. The ratio of length to radius of a pipe should be greater than 1/48 of the Reynolds number for the Hagen–Poiseuille law to be valid. If the pipe is too short, the Hagen–Poiseuille equation may result in unphysically high flow rates; the flow is bounded by Bernoulli's principle, under less restrictive conditions, by
In February 2013, Essendon announced that they had asked the Australian Sports Anti-Doping Authority (ASADA) to investigate the supplements program that Dank had overseen at their club during the 2012 season. A former player, Kyle Reimers, had claimed that the players were asked to sign waivers and were injected with supplements that were "pushing the boundaries". Another former player, Mark McVeigh countered that the injections were only vitamins and all were completely legal and not on any World Anti-Doping Agency (WADA) banned substance list. Dank left Essendon at the end of the 2012 season, and high-performance manager Dean 'The Weapon' Robinson was suspended from the club after the announcement of the investigation. Stephen Dank controversially admitted to a Fairfax journalist that he had been using thymosin beta 4 on Essendon players. When journalist Nick McKenzie pointed out that that drug was prohibited by WADA under its S2 classification, Dank hesitated and then seemed extremely surprised: "Well, that must have just only come in this year and I will get someone to speak to ASADA about that. That's just mind-blowing." After 24 hours, Dank informed Fairfax media that he was actually really talking about thymomodulin which was a permitted substance. In 2015, the AFL Tribunal found him guilty of trafficking in a number of illicit supplements and banned him from any association with the AFL for life. Since most Australian sporting organisations honour sanctions imposed by other leagues, this had the effect of blackballing Dank from major Australian sport.
Sources: en.wikipedia.org
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.
No. No major regulatory authority lists an approved product under this name, and no pharmacopoeial monograph exists for it. Material sold under the label is therefore supplied outside approved pharmaceutical channels, which affects the quality documentation available.
It falls within a prohibited class covering peptide hormones and growth factors, based on presumed effects on tissue repair and blood vessel formation. Anti-doping laboratories have published mass spectrometry methods for detecting thymosin beta-4 related peptides in urine samples.
The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.